Treatment of obsessive-compulsive disorder in patients who have comorbid major depression

Journal of Clinical Psychology

Volumn 60, Issue 11, 2004, Pages 1133-1141

  Abramowitz, Jonathan S ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cognitive behavioral therapy; Comorbidity; Major depression; Obsessive compulsive disorder

Indexed keywords

CLOMIPRAMINE; IMIPRAMINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANXIETY DISORDER; BEHAVIOR THERAPY; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; DISEASE SEVERITY; HUMAN; MAJOR DEPRESSION; MALE; MOOD DISORDER; OBSESSIVE COMPULSIVE DISORDER; PERSONALITY DISORDER; PSYCHIATRIC DIAGNOSIS; REVIEW; SCORING SYSTEM; SYMPTOM; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; CLINICAL TRIALS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 6344275149     PISSN: 00219762     EISSN: None     Source Type: Journal    
DOI: 10.1002/jclp.20078     Document Type: Review

References (20)

1. Abramowitz, J.S., & Foa, E.B. (1998). Worries and obsessions in individuals with obsessive-compulsive disorder with and without generalized anxiety disorder. Behaviour Research and Therapy, 36, 695-700.
2. Abramowitz, J.S., & Foa, E.B. (2000). Does comorbid major depressive disorder influence outcome of exposure and response prevention for OCD? Behavior Therapy, 31, 795-800.
3. Abramowitz, J.S., Franklin, M.E., Street, G., Kozak, M., & Foa, E.B. (2000). Effects of comorbid depression on response to treatment for obsessive-compulsive disorder. Behavior Therapy, 31, 517-528.
4. Antony, M.M., Downie, F., & Swinson, R.P. (1998). Diagnostic issues and epidemiology in obsessive-compulsive disorder. In R.P. Swinson, M. Antony, S. Rachman, & M. Richter (Eds.), Obsessive-compulsive disorder: Theory, research, and treatment (pp. 3-32). New York: Guilford.
5. Basoglu, M., Lax, T., Kasvikis, Y., & Marks, I. (1988). Predictors of improvement in obsessive-compulsive disorder. Journal of Anxiety Disorders, 2, 299-317.
6. Cottrax, J., Messy, P., Marks, I., Mollard, E., & Bouvard, M. (1993). Predictive factors in the treatment of obsessive-compulsive disorder with fluvoxamine and/or behavior therapy. Behavioural Psychotherapy, 21, 45-50.
7. Elkin, I., Shea, M., Watkins, J.T., Imber, S., Sotsky, S., Cllins, J., Glass, D., Pilkonis, P., Leber, W., Docherty, J., Fiester, S., & Parloff, M. (1989). National Institute of Mental Health Treatment of Depression Collaborative Research program: General effectiveness of treatments. Archives of General Psychiatry, 46, 971-982.
8. Foa, E.B., Grayson, J.B., Steketee, G.S., Doppelt, H.G., Turner, R.M., & Latimer, P.R. (1983). Success and failure in the behavioral treatment of obsessive-compulsives. Journal of Consulting and Clinical Psychology, 51, 287-297.
9. Foa, E.B., & Kozak, M.J. (1996). Psychological treatment for obsessive-compulsive disorder. In M.R. Mavissakalian & R.F. Prien (Eds.), Long-term treatments of anxiety disorders (pp. 285-309). Washington DC: American Psychiatric Press.
10. Foa, E.B., Kozak, M.J., Steketee, G., & McCarthy, P.R. (1992). Treatment of depressive and obsessive-compulsive symptoms in OCD by imipramine and behavior therapy. British Journal of Clinical Psychology, 31, 279-292.
11. Franklin, M.E., Abramowitz, J.S., Kozak, M.J., Levine, J., & Foa, E.B. (2000). Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: A comparison of randomized and clinic patients. Journal of Consulting and Clinical Psychology, 68, 594-602.
12. Marks, I.M., Stern, R., Mawson, D., Cobb, J., & McDonald, R. (1980). Clomipramine and exposure for obsessive-compulsive rituals. Part 1. British Journal of Psychiatry, 136, 1-25.
13. Nestadt, G., Samuels, J., Riddle, M., Liang, K.-Y., Bienvenu, O., Hoehn-Saric, R., Grados, M., & Cullen, B. (2001). The relationship between obsessive-compulsive disorder and anxiety and affective disorders: Results from the Johns Hopkins OCD Family Study. Psychological Medicine, 31, 481-487.
14. Pigott, T., & Seay, S. (1998). Biological treatments for obsessive-compulsive disorder: Literature review. In R. Swinson, M. Antony, S. Rachman, & M. Richter (Eds.), Obsessive-compulsive disorder: Theory research and practice (pp. 298-326). New York: Guilford.
15. Ricciardi, J.N., & McNally, R.J. (1995). Depressed mood is related to obsessions but not compulsions in obsessive-compulsive disorder. Journal of Anxiety Disorders, 9, 249-256.
16. Salkovskis, P.M., & Warwick, H.M. (1985). Cognitive therapy of obsessive-compulsive disorder: Treating treatment failures. Behavioural Psychotherapy, 13, 243-255.
17. Sanderson, W., DiNardo, P., Rapee, R., & Barlow, D. (1990). Syndrome comorbidity in patients diagnosed with a DSM-III-R anxiety disorder. Journal of Abnormal Psychology, 99, 308-312.
18. Steketee, G. (1993). Social support as a predictor of follow-up following treatment for OCD. Journal of Behavioral Psychotherapy, 21, 81-95.
19. Steketee, G.S. (1999). Therapist protocol for overcoming obsessive-compulsive disorder: A behavioral and cognitive protocol for the treatment of OCD. Oakland, CA: New Harbinger.
20. Steketee, G.S., Chambless, D.L., & Tran, G. (2001). Effects of Axis I and II comorbidity on behavior therapy outcome for obsessive-compulsive disorder and agoraphobia. Comprehensive Psychiatry, 42, 76-86.